Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- PNAX.TA
- Price
- -
- Stock movement down
- -55.00 (-1.05%)
- Company name
- Panaxia Labs Israel Ltd
- Exchange
- (TA ,
- Currency
- ILA )
- Sector
- Healthcare >Drug Manufacturers - Specialty & Generic
- Market cap
- 777.32M
- Ent value
- 817.90M
- Price/Sales
- 47.93
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -0.15%
- 3 year return
- -69.91%
- 5 year return
- -59.54%
- 10 year return
- -30.33%
Last updated: 2024-12-17
DIVIDENDS
PNAX.TA does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 47.93 |
| Price to Book | - |
| EV to Sales | 50.43 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 149.71K |
| EPS (TTM) | -168.66 |
| FCF per share (TTM) | -72.18 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 16.22M |
| Gross profit (TTM) | -15.13M |
| Operating income (TTM) | -20.94M |
| Net income (TTM) | -25.52M |
| EPS (TTM) | -168.66 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | -93.31% |
| Operating margin (TTM) | -129.12% |
| Profit margin (TTM) | -157.37% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 281.00K |
| Net receivables | 6.00K |
| Total current assets | 4.02M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 13.22M |
| Total assets | 5.25M |
| Accounts payable | 3.52M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 19.98M |
| Total liabilities | 40.86M |
| Shareholder's equity | -35.62M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -10.81M |
| Capital expenditures (TTM) | 110.00K |
| Free cash flow (TTM) | -10.92M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | -486.47% |
| Return on Invested Capital | 173.20% |
| Cash Return on Invested Capital | 74.13% |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| PNAX.TA | S&P500 | |
| Current price drop from All-time high | -99.88% | - |
| Highest price drop | -99.90% | -56.47% |
| Date of highest drop | 18 Jun 2023 | 9 Mar 2009 |
| Avg drop from high | -91.29% | -11.07% |
| Avg time to new high | 465 days | 12 days |
| Max time to new high | 4156 days | 1805 days |
COMPANY DETAILS
Marketcap
777.32M
Marketcap category
Small-cap
Description
Panaxia Labs Israel Ltd provides pharmaceutical solutions for patients and physicians in Israel and internationally. It offers pharma-grade smokeless cannabis products, such as oral tablets, orodispersible tablets, sublingual tablets, oral oils, sublingual drops, solution for inhalation, pastilles, topicals, suppositories, and cannabis extracts in ethanol under the NAXIVA " PANAXOL, NAXIVA-PANAXOL-ONKO, PANAXIR SENSE, PANAXIR, Axiban, Tikva, Ultra Health, and Salus brands. The company was incorporated in 2005 and is based in Lod, Israel.
Employees
10
Website
Investor relations
-
SEC filings
CEO
Country
Israel
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found